Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide

被引：58
|
作者：
Singh, Naveena [1 ]
Gilks, C. Blake [2 ]
Hirschowitz, Lynn [3 ]
Kehoe, Sean [4 ]
McNeish, Iain A. [5 ]
Miller, Dianne [6 ,7 ]
Naik, Raj [8 ]
Wilkinson, Nafisa [9 ]
McCluggage, W. Glenn [10 ]
机构：
[1] Barts Hlth NHS Trust, Dept Cellular Pathol, 80 Newark St, London E11 1LT, England
[2] Vancouver Gen Hosp, Dept Anat Pathol, 1st Floor JPPN,855 West 12th Ave, Vancouver, BC V5Z 1M9, Canada
[3] Birmingham Womens NHS Trust, Dept Cellular Pathol, Mindelsohn Way, Birmingham B15 2TG, W Midlands, England
[4] Univ Birmingham, Inst Canc & Genom, Birmingham B15 2TT, W Midlands, England
[5] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Inst Canc Sci, Beatson Inst Canc Res, Glasgow G61 1QH, Lanark, Scotland
[6] Vancouver Gen Hosp, Div Gynecol Oncol, 6th Floor Gynecol,2775 Laurel St, Vancouver, BC V5Z 1M9, Canada
[7] British Columbia Canc Agcy, Gordon & Leslie Diamond Hlth Care Ctr, 6th Floor Gynecol,2775 Laurel St, Vancouver, BC V5Z 1M9, Canada
[8] Queen Elizabeth Hosp, Dept Gynaecol Oncol, Queen Elizabeth Ave, Gateshead NE9 6SX, Tyne & Wear, England
[9] St James Hosp, Dept Pathol, Beckett St, Leeds LS9 7TF, W Yorkshire, England
[10] Royal Victoria Hosp, Dept Pathol Belfast Hlth & Social Care Trust, Grosvenor Rd, Belfast BT12 6BA, Antrim, North Ireland
来源：
GYNECOLOGIC ONCOLOGY | 2016年 / 141卷 / 02期
关键词：
Ovary; High-grade serous carcinoma; Fallopian tube; Primary peritoneal carcinoma; Pathology; Origin; FALLOPIAN-TUBE; INTRAEPITHELIAL CARCINOMA; FIMBRIA; OVARY; ORIGIN; SYSTEM; BRCA;
D O I：
10.1016/j.ygyno.2015.10.022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：195 / 198
页数：4
相关论文
共 50 条
  • [21] TP53-wildtype High-Grade Serous Tubo-Ovarian Carcinomas
    Chui, M. Herman
    Soslow, Robert
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1029 - 1029
  • [22] Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma
    Hollis, Robert L.
    Croy, Ian
    Churchman, Michael
    Bartos, Clare
    Rye, Tzyvia
    Gourley, Charlie
    Herrington, C. Simon
    BRITISH JOURNAL OF CANCER, 2022, 127 (06) : 1034 - 1042
  • [23] Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma
    Robert L. Hollis
    Ian Croy
    Michael Churchman
    Clare Bartos
    Tzyvia Rye
    Charlie Gourley
    C. Simon Herrington
    British Journal of Cancer, 2022, 127 : 1034 - 1042
  • [24] Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles
    Magrill, Jamie
    Karnezis, Anthony N.
    Tessier-Cloutier, Basile
    Talhouk, Aline
    Kommoss, Stefan
    Cochrane, Dawn
    Chow, Christine
    Cheng, Angela
    Soslow, Robert
    Hauptmann, Steffen
    du Bois, Andreas
    Pfisterer, Jacobus
    Gilks, C. Blake
    Huntsman, David G.
    Kommoss, Friedrich
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2019, 38 (06) : 552 - 561
  • [25] Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinoma
    Tessier-Cloutier, Basile
    Cochrane, Dawn R.
    Karnezis, Anthony N.
    Colborne, Shane
    Magrill, Jamie
    Talhouk, Aline
    Zhang, Jonathan
    Leung, Samuel
    Hughes, Christopher S.
    Piskorz, Anna
    Cheng, Angela S.
    Greening, Kendall
    du Bois, Andreas
    Pfisterer, Jacobus
    Soslow, Robert A.
    Kommoss, Stefan
    Brenton, James D.
    Morin, Gregg B.
    Gilks, C. Blake
    Huntsman, David G.
    Kommoss, Friedrich
    HUMAN PATHOLOGY, 2020, 101 : 40 - 52
  • [26] Intralymphatic Histiocytosis Associated With Tubo-ovarian High-grade Serous Carcinoma: Case Report and Review of the Literature
    Bonometti, Arturo
    Carbone, Riccardo
    Cassani, Chiara
    Dioli, Claudia
    Lucato, Elena
    Spinillo, Arsenio
    Paulli, Marco
    Cesari, Stefania
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (02) : 192 - 195
  • [27] Prognostic value of progesterone receptor expression in tubo-ovarian high-grade serous carcinoma of the COEUR cohort
    Le Page, Cecile
    Rahimi, Kurosh
    Mes-Masson, Anne-Marie
    Kobel, Martin
    HISTOPATHOLOGY, 2019, 74 (04) : 663 - 666
  • [28] Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
    Wang, Chen
    Block, Matthew S.
    Cunningham, Julie M.
    Sherman, Mark E.
    McCauley, Bryan M.
    Armasu, Sebastian M.
    Vierkant, Robert A.
    Traficante, Nadia
    Talhouk, Aline
    Doherty, Jennifer A.
    Pejovic, Nadja
    Kobel, Martin
    Jorgensen, Brooke D.
    Garsed, Dale W.
    Fereday, Sian
    Ramus, Susan J.
    Ariyaratne, Dinuka
    Anglesio, Michael S.
    Widschwendter, Martin
    Pejovic, Tanja
    Bosquet, Jesus Gonzalez
    Bowtell, David D.
    Winham, Stacey J.
    Goode, Ellen L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (03) : 542 - 549
  • [29] Rare case of paraneoplastic cerebellar degeneration secondary to high-grade serous carcinoma of tubo-ovarian origin
    Butt, Eman
    Tadross, John A.
    Chadda, Karan R.
    Latimer, John
    BMJ CASE REPORTS, 2019, 12 (08)
  • [30] Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC)
    Ditzel, Helena M.
    Strickland, Kyle C.
    Meserve, Emily E.
    Stover, Elizabeth
    Konstantinopoulos, Panagiotis A.
    Matulonis, Ursula A.
    Muto, Michael G.
    Liu, Joyce F.
    Feltmate, Colleen
    Horowitz, Neil
    Berkowitz, Ross S.
    Gupta, Mamta
    Hecht, Jonathan L.
    Lin, Douglas I.
    Jochumsen, Kirsten M.
    Welch, William R.
    Hirsch, Michelle S.
    Quade, Bradley J.
    Lee, Kenneth R.
    Crum, Christopher P.
    Mutter, George L.
    Nucci, Marisa R.
    Howitt, Brooke E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2019, 38 (03) : 230 - 240
12345